In recent years, SPRAVATO® has emerged as a groundbreaking treatment option for individuals suffering from treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation. This FDA-approved nasal spray, which contains esketamine, offers a new avenue for those who have not found relief through traditional antidepressants. In this blog, we will explore how quickly SPRAVATO® works, the treatment timeline, and what patients can expect during their care at West Coast Ketamine Center in San Diego, CA.
What Is SPRAVATO® and Who Is It For?
SPRAVATO® is an FDA-approved nasal spray specifically designed for adults diagnosed with treatment-resistant depression and major depressive disorder accompanied by suicidal thoughts. Treatment-resistant depression is defined as a condition where patients have not responded adequately to at least two different antidepressant medications. SPRAVATO® works differently than traditional antidepressants, targeting the NMDA receptor in the brain to provide rapid relief from depressive symptoms.
Indications for Use
- Treatment-Resistant Depression (TRD): For patients who have not responded to at least two different antidepressant treatments.
- Major Depressive Disorder (MDD) with Suicidal Ideation: For individuals experiencing severe depression with thoughts of self-harm or suicide.
Understanding the SPRAVATO® Treatment Timeline
One of the most compelling aspects of SPRAVATO® is its potential for rapid symptom relief. While individual experiences may vary, many patients report feeling some relief within hours or days of their first dose. However, for most patients, the full therapeutic effects are typically observed within four to six weeks of starting treatment.
Treatment Phases
The SPRAVATO® treatment process is divided into two main phases: the induction phase and the maintenance phase.
Induction Phase
- Frequency: Patients receive SPRAVATO® twice a week for the first four weeks.
- Duration: This phase is crucial for establishing the initial response to the treatment.
Maintenance Phase
- Frequency: After the induction phase, patients transition to a maintenance schedule, which may involve weekly or biweekly treatments.
- Goal: The aim of this phase is to sustain the benefits achieved during the induction phase.
It is important to note that SPRAVATO® is always administered in conjunction with an oral antidepressant to enhance its effectiveness.
What to Expect During Each Phase of Care
Induction Phase
During the induction phase, patients will visit West Coast Ketamine Center for their SPRAVATO® administration. The treatment is administered under the supervision of a qualified healthcare professional to ensure safety and monitor for any potential side effects. Patients may experience mild dissociative effects, which are typically transient and resolve shortly after administration.
Maintenance Phase
Once the induction phase is complete, patients will continue to receive SPRAVATO® on a less frequent basis. This phase is designed to maintain the improvements in mood and overall mental health. Regular follow-up appointments will be scheduled to assess progress and make any necessary adjustments to the treatment plan.
SPRAVATO® Administration at West Coast Ketamine Center in San Diego
At West Coast Ketamine Center, we are committed to providing comprehensive care for individuals seeking relief from depression. Our services include:
- SPRAVATO® Administration: We offer SPRAVATO® for FDA-approved indications, ensuring that patients receive the most appropriate care for their specific needs.
- IV Ketamine Therapy: In addition to SPRAVATO®, we provide intravenous ketamine therapy, which has also shown promise in treating depression and other mood disorders.
- Ketamine-Assisted Psychotherapy: Our center offers ketamine-assisted psychotherapy, combining the benefits of ketamine with therapeutic support to enhance treatment outcomes.
- Psychiatric Medication Management: Our team provides ongoing medication management to ensure that patients receive the best possible care throughout their treatment journey.
For more information about our services or to schedule an intake appointment, please visit our clinic or contact us.
Recap
SPRAVATO® is a revolutionary treatment option for individuals suffering from treatment-resistant depression and major depressive disorder with suicidal ideation. While some patients may experience relief within hours or days, most will see full results within four to six weeks. The treatment process involves an initial induction phase followed by a maintenance phase, with all treatments administered in-office under professional supervision.
If you or a loved one is struggling with depression and seeking effective treatment options, we encourage you to reach out to West Coast Ketamine Center. Our dedicated team is here to support you on your journey to recovery.
Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.
